Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ)
CNY 4.2
(-0.94%)
CNY 4.2
(-0.94%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 122.75 Million CNY | -25.13% |
| 2022 | 97.51 Million CNY | 8.32% |
| 2021 | 218.91 Million CNY | 15.14% |
| 2020 | 157.08 Million CNY | -59.69% |
| 2019 | 365.75 Million CNY | 106.61% |
| 2018 | 114.8 Million CNY | 28.14% |
| 2017 | 71.61 Million CNY | 1.01% |
| 2016 | 133.23 Million CNY | -0.29% |
| 2015 | 107.16 Million CNY | 202.85% |
| 2014 | 28.7 Million CNY | -35.72% |
| 2013 | 68.55 Million CNY | 22.88% |
| 2012 | 55.56 Million CNY | 27.48% |
| 2011 | 42.12 Million CNY | 28.07% |
| 2010 | 37.59 Million CNY | 12.37% |
| 2009 | 25.07 Million CNY | 6.87% |
| 2008 | 27.14 Million CNY | 98.87% |
| 2007 | 14.87 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 854.5 Thousand CNY | -145.53% |
| 2024 Q1 | -10.25 Million CNY | -201.36% |
| 2024 Q2 | 17.27 Million CNY | 313.29% |
| 2023 FY | - CNY | -25.13% |
| 2023 Q4 | 10.12 Million CNY | -38.97% |
| 2023 Q2 | 18.98 Million CNY | 603.73% |
| 2023 Q3 | 16.58 Million CNY | -12.66% |
| 2023 Q1 | 2.69 Million CNY | 104.48% |
| 2022 Q1 | -27.64 Million CNY | -345.51% |
| 2022 FY | - CNY | 8.32% |
| 2022 Q4 | -60.25 Million CNY | -129.34% |
| 2022 Q3 | 205.38 Million CNY | 1188.79% |
| 2022 Q2 | -18.86 Million CNY | 31.76% |
| 2021 Q2 | 19.23 Million CNY | -63.04% |
| 2021 Q1 | 52.05 Million CNY | 58.93% |
| 2021 FY | - CNY | 15.14% |
| 2021 Q3 | -5.56 Million CNY | -128.93% |
| 2021 Q4 | 11.25 Million CNY | 302.31% |
| 2020 FY | - CNY | -59.69% |
| 2020 Q1 | 9.94 Million CNY | -66.83% |
| 2020 Q3 | 54.38 Million CNY | 13949.82% |
| 2020 Q4 | 32.75 Million CNY | -39.78% |
| 2020 Q2 | -392.71 Thousand CNY | -103.95% |
| 2019 Q2 | 63.79 Million CNY | 170.78% |
| 2019 Q4 | 29.97 Million CNY | -83.28% |
| 2019 FY | - CNY | 106.61% |
| 2019 Q3 | 179.31 Million CNY | 181.1% |
| 2019 Q1 | 23.55 Million CNY | -45.99% |
| 2018 Q3 | 58.46 Million CNY | 1563.47% |
| 2018 FY | - CNY | 28.14% |
| 2018 Q4 | 43.61 Million CNY | -25.4% |
| 2018 Q2 | -3.99 Million CNY | 18.47% |
| 2018 Q1 | -4.9 Million CNY | -107.35% |
| 2017 Q4 | 66.69 Million CNY | 2025.34% |
| 2017 Q3 | -3.46 Million CNY | 66.1% |
| 2017 Q1 | -4.75 Million CNY | -106.77% |
| 2017 FY | - CNY | 1.01% |
| 2017 Q2 | -10.21 Million CNY | -114.69% |
| 2016 Q3 | -1.7 Million CNY | -130.0% |
| 2016 Q2 | 5.66 Million CNY | 182.0% |
| 2016 Q4 | 70.3 Million CNY | 4232.83% |
| 2016 Q1 | -6.91 Million CNY | -118.38% |
| 2016 FY | - CNY | -0.29% |
| 2015 Q4 | 37.62 Million CNY | 37.47% |
| 2015 FY | - CNY | 202.85% |
| 2015 Q2 | 20.77 Million CNY | 218.73% |
| 2015 Q3 | 27.36 Million CNY | 31.72% |
| 2015 Q1 | 6.51 Million CNY | 240.43% |
| 2014 FY | - CNY | -35.72% |
| 2014 Q4 | -4.64 Million CNY | 65.84% |
| 2014 Q3 | -13.58 Million CNY | -200.32% |
| 2014 Q2 | 13.54 Million CNY | 394.78% |
| 2014 Q1 | -4.59 Million CNY | -124.57% |
| 2013 Q3 | 9.78 Million CNY | -4.04% |
| 2013 FY | - CNY | 22.88% |
| 2013 Q4 | 18.69 Million CNY | 91.03% |
| 2013 Q1 | -5.9 Million CNY | -127.58% |
| 2013 Q2 | 10.2 Million CNY | 272.8% |
| 2012 Q3 | 8.76 Million CNY | -55.03% |
| 2012 FY | - CNY | 27.48% |
| 2012 Q2 | 19.48 Million CNY | 533.64% |
| 2012 Q1 | -4.49 Million CNY | -120.33% |
| 2012 Q4 | 21.4 Million CNY | 144.32% |
| 2011 Q2 | 11.23 Million CNY | 4961.89% |
| 2011 Q1 | -231.09 Thousand CNY | -101.63% |
| 2011 Q3 | 7.05 Million CNY | -37.22% |
| 2011 Q4 | 22.1 Million CNY | 213.32% |
| 2011 FY | - CNY | 28.07% |
| 2010 Q2 | 16.71 Million CNY | 1339.52% |
| 2010 Q1 | -1.34 Million CNY | -105.51% |
| 2010 FY | - CNY | 12.37% |
| 2010 Q4 | 14.18 Million CNY | 6.78% |
| 2010 Q3 | 13.28 Million CNY | -20.51% |
| 2009 FY | - CNY | 6.87% |
| 2009 Q4 | 24.48 Million CNY | 2179.42% |
| 2009 Q3 | 1.07 Million CNY | 0.0% |
| 2008 FY | - CNY | 98.87% |
| 2007 FY | - CNY | 0.0% |